openPR Logo
Press release

Keloid Treatment Market is likely to register double digit CAGR during 2016 to 2024

10-23-2017 08:37 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Keloid Treatment Market is likely to register double digit CAGR

The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. There are several established treatment options available for keloid scars, including laser treatment, surgery, radiation, steroid injections, cryotherapy, and interferon. Moreover, there are a number of products available in the market today to hasten the healing of keloids. These include creams, sprays, gel sheets, ointments, elastic wraps, oils, and topical gels.

While most keloid scars are benign, the continuous growth of the scar may result in skin cancer and this is a key factor driving the market for keloid treatment. Several pharmaceutical and biopharmaceutical companies, medical centers, and universities have been conducting clinical trials for the development of drugs and treatment options for keloid scars.

View and Download Report ToC for more Professional & Technical industry insights: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=12152

The report offers readers a detailed assessment of the ongoing economic, technical, consumer, regional, and political trends impacting the trajectory of the global keloid treatment market. The bargaining power of prominent buyers and suppliers, the threat presented by new entrants and substitutes, and the intensity of rivalry among key players have been thoroughly evaluated in the report with the help of the Porter’s Five Forces analysis model. An extensive overview of the competitive landscape of the keloid treatment market has also been provided, which focuses on the business overview, recent developments, product and service portfolio, and financial outlook of the leading companies.

Global Keloid Treatment Market: Growth Drivers and Restraints

The global keloid treatment market is primarily driven by rapid technological advancement in skin care as well as in keloid scar removal and the growing awareness among patients regarding the availability of these products and treatment options. Changing lifestyles, the ever-rising focus on appearance and aesthetics, and the increasing expenditure on personal care products and services have also significantly contributed toward the expansion of the keloid treatment market. Demand for radiation therapy, surgical intervention, and steroid injections is supported by the growing trust and acceptance of the patients, thereby ensuring that the keloid treatment market registers a healthy growth over the forecast period.

On the flip side, however, this market is being hampered by the possible side effects of keloid treatment, the high cost of various treatment options, and the risk of extreme pain and complications during treatment.

Global Keloid Treatment Market: Region-wise Outlook

The global market for keloid treatment is segmented on the basis of geography into Europe, North America, Asia Pacific, and Rest of the World. North America is the dominant regional market for keloid treatment and is likely to retain its lead through 2024. High disposable income of people in this region, coupled with the comparatively high availability as well as acceptance of new technologies, products, and treatment alternatives are responsible for the rapid growth of the North America keloid treatment market. Europe is also a major market for keloid treatment driven mainly by the favorable reimbursement scenario for skin treatment and the increasing awareness of the consumer.

Asia Pacific is an immensely promising market for keloid treatment owing to the increased focus on appearance and aesthetics in several emerging economies. The rapid growth in population, increasing disposable incomes, and improving healthcare facilities in the region are also anticipated to boost the market for keloid treatment in Asia Pacific.

Ask for Discount for Premium Research Report (US$ 5795) With Complete TOC: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12152

Global Keloid Treatment Market: Competitive Landscape

There are a number of players competing in the global keloid treatment market. These include Pacific World Corporation, Revitol Corporation Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Novartis AG, Renovo Group plc., Valeant Pharmaceuticals International Inc., Galena Biopharma, Inc., RXi Pharmaceuticals, Inc., and Avita Medical.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
90 State Street,
Suite 700
Albany NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
E-mail: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Keloid Treatment Market is likely to register double digit CAGR during 2016 to 2024 here

News-ID: 780601 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Keloid

Keloid Treatment Market: Intralesional corticosteroid injections to remain most …
According to the latest market report published by Future Market Insights titled‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),’the global keloid treatment market is estimated to be worth US$ 3,145.8 Mn by 2017 end, and is expected to expand at a CAGR of 3.4% over the forecast period of 2017–2027 to reach a market valuation of US$ 4,414.6 Mn by the end of 2027. To know key findings
Keloid Treatment Market Professional Survey Report 2024
Global Keloid Treatment Market: Overview The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. Request Brochure- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12152 There are several established treatment options available for keloid scars, including laser
Global Keloid Treatment Market Analysis & Opportunity Assessment till 2027
A latest research report titled as “Keloid Treatment Market: Excision Projected to be the Most Attractive Treatment Type During the Forecast Period: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable
Keloid Treatment Market -
Global Keloid Treatment Market: Overview The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. There are several established treatment options available for keloid scars, including laser
Keloid Treatment Market Professional Survey Report 2024
Global Keloid Treatment Market: Overview The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. There are several established treatment options available for keloid scars, including laser treatment,
Keloid Treatment Market, Industry Analysis, Research Report 2024
Global Keloid Treatment Market: Overview The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. There are several established treatment options available for keloid scars, including laser